Inflammation as a mediator of the association between race and atrial fibrillation results from the health ABC study (Health, Aging, and Body Composition)

JACC: Clinical Electrophysiology

Volumn 1, Issue 4, 2015, Pages 248-255

  Dewland, Thomas A ^a,b   Vittinghoff, Eric ^a   Harris, Tamara B ^c   Magnani, Jared W ^d   Liu, Yongmei ^e   Hsu, Fang Chi ^e   Satterfield, Suzanne ^f   Wassel, Christina ^g   Marcus, Gregory M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^g UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

atrial fibrillation; inflammation; race

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; SOLUBLE INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA SOLUBLE RECEPTOR I; TUMOR NECROSIS FACTOR ALPHA SOLUBLE RECEPTOR II; UNCLASSIFIED DRUG;

ABDOMINAL OBESITY; ABDOMINAL SUBCUTANEOUS FAT; AGED; ARTICLE; ATRIAL FIBRILLATION; BLACK PERSON; CARDIOVASCULAR RISK; CAUCASIAN; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT;

EID: 84944066128     PISSN: 2405500X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacep.2015.04.014     Document Type: Article

References (37)

1. T.A. Dewland, J.E. Olgin, E. Vittinghoff, and G.M. Marcus Incident atrial fibrillation among Asians, Hispanics, blacks, and whites Circulation 128 2013 2470 2477
2. A. Alonso, S.K. Agarwal, E.Z. Soliman, and et al. Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study Am Heart J 158 2009 111 117
3. A. Frustaci, C. Chimenti, F. Bellocci, E. Morgante, M.A. Russo, and A. Maseri Histological substrate of atrial biopsies in patients with lone atrial fibrillation Circulation 96 1997 1180 1184
4. T.T. Issac, H. Dokainish, and N.M. Lakkis Role of inflammation in initiation and perpetuation of atrial fibrillation J Am Coll Cardiol 50 2007 2021 2028
5. M.K. Chung, D.O. Martin, D. Sprecher, and et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation Circulation 104 2001 2886 2891
6. R.J. Aviles, D.O. Martin, C. Apperson-Hansen, and et al. Inflammation as a risk factor for atrial fibrillation Circulation 108 2003 3006 3010
7. R.B. Schnabel, M.G. Larson, J.F. Yamamoto, and et al. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community Circulation 121 2010 200 207
8. G.M. Marcus, M.A. Whooley, D.V. Glidden, L. Pawlikowska, J.G. Zaroff, and J.E. Olgin Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study Am Heart J 155 2008 303 309
9. J.N. Fain Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review Mediators Inflamm 2010 2010 513948-20
10. T.J. Wang, H. Parise, D. Levy, and et al. Obesity and the risk of new-onset atrial fibrillation JAMA 292 2004 2471 2477
11. L. Frost, L.J. Hune, and P. Vestergaard Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health study Am J Med 118 2005 489 495
12. R.R. Huxley, J.R. Misialek, S.K. Agarwal, and et al. Physical activity, obesity, weight change and risk of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study Circ Arrhythm Electrophysiol 2014 CIRCEP.113.001244
13. M. Visser, M. Pahor, D.R. Taaffe, and et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC study J Gerontol A Biol Sci Med Sci 57 2002 M326 M332
14. A. Khera, D.K. McGuire, S.A. Murphy, and et al. Race and gender differences in C-reactive protein levels J Am Coll Cardiol 46 2005 464 469
15. M.W. Hulver, O. Saleh, K.G. MacDonald, W.J. Pories, and H.A. Barakat Ethnic differences in adiponectin levels Metab Clin Exp 53 2004 1 3
16. C.L. Wassel Fyr, A.M. Kanaya, S.R. Cummings, and et al. Genetic admixture, adipocytokines, and adiposity in black Americans: the Health, Aging, and Body Composition study Hum Genet 121 2007 615 624
17. P.T. Katzmarzyk, G.A. Bray, F.L. Greenway, and et al. Racial differences in abdominal depot-specific adiposity in white and African American adults Am J Clin Nutr 91 2010 7 15
18. National Institute on Aging, Nations Institutes of Health. Health ABC. Available at: http://www.grc.nia.nih.gov/branches/leps/healthabc/index.htm. Accessed July 2015.
19. K. Yaffe, A. Kanaya, K. Lindquist, and et al. The metabolic syndrome, inflammation, and risk of cognitive decline JAMA 292 2004 2237 2242
20. J.A. Cauley, M.E. Danielson, R.M. Boudreau, and et al. Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition study J Bone Miner Res 22 2007 1088 1095
21. M.B. Snijder, M. Visser, J.M. Dekker, and et al. The prediction of visceral fat by dual-energy X-ray absorptiometry in the elderly: a comparison with computed tomography and anthropometry Int J Obes Relat Metab Disord 26 2002 984 993
22. K. Imai, L. Keele, and D. Tingley A general approach to causal mediation analysis Psychol Methods 15 2010 309 334
23. D.Y. Lin, T.R. Fleming, and V. De Gruttola Estimating the proportion of treatment effect explained by a surrogate marker Stat Med 16 1997 1515 1527
24. M. Rienstra, J.X. Sun, S.A. Lubitz, and et al. Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring study Am Heart J 163 2012 119 124
25. M. Knuiman, T. Briffa, M. Divitini, and et al. A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health study Eur J Epidemiol 29 2014 181 190
26. T. Cheng, X.-F. Wang, Y.-T. Hou, and L. Zhang Correlation between atrial fibrillation, serum amyloid protein A and other inflammatory cytokines Mol Med Rep 6 2012 581 584
27. C.X. Wong, H.S. Abed, P. Molaee, and et al. Pericardial fat is associated with atrial fibrillation severity and ablation outcome J Am Coll Cardiol 57 2011 1745 1751
28. T. Mazurek, L. Zhang, A. Zalewski, and et al. Human epicardial adipose tissue is a source of inflammatory mediators Circulation 108 2003 2460 2466
29. G.M. Marcus, A. Alonso, C.A. Peralta, and et al. European ancestry as a risk factor for atrial fibrillation in African Americans Circulation 122 2010 2009 2015
30. H.S. Abed, G.A. Wittert, D.P. Leong, and et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial JAMA 310 2013 2050 2060
31. N.L. Glazer, S. Dublin, N.L. Smith, and et al. Newly detected atrial fibrillation and compliance with antithrombotic guidelines Arch. Intern Med 167 2007 246 252
32. B. Ruo, A.M. Capra, N.G. Jensvold, and A.S. Go Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study J Am Coll Cardiol 43 2004 429 435
33. A.S. Go, E.M. Hylek, K.A. Phillips, and et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study JAMA 285 2001 2370 2375
34. G.M. Marcus, L.M. Smith, K. Ordovas, and et al. Intracardiac and extracardiac markers of inflammation during atrial fibrillation Heart Rhythm 7 2010 149 154
35. G.M. Marcus, L.M. Smith, D.V. Glidden, and et al. Markers of inflammation before and after curative ablation of atrial flutter Heart Rhythm 5 2008 215 221
36. M. Rotter, P. Jaïs, M.-C. Vergnes, and et al. Decline in C-reactive protein after successful ablation of long-lasting persistent atrial fibrillation J Am Coll Cardiol 47 2006 1231 1233
37. E.M. Kallergis, E.G. Manios, E.M. Kanoupakis, and et al. The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation Heart 94 2008 200 204